Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Prospectively evaluate the predictive value of individual pre-specified clinical extubation criteria for extubation success
Perform a prospective observational study to evaluate routine criteria commonly used to extubate elderly patients in the operating room after non-cardiac and non-thoracic surgery to ultimately reduce the incidence of near-term reintubation and by extension other respiratory complications
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patients undergoing general endotracheal anesthesia that will be extubated following the procedure | Patients 60 years of age and older undergoing general anesthesia and non-cardiac surgery will be observed by a member of the research team independent from the team caring for the patient at the time of emergence and extubation |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Extubation Success or Extubation requiring Intervention | Quality of extubation will be assessed using a standard rubric for all extubation. | Day 1 |
| Presence or Absence of specific extubation criteria. | Assess the presence of specific extubation criteria met during extubation from the following list: Following Commands, Tidal volume>4 cc/kg, Conjugate gaze, End-tidal CO2 (ETCO2) <55 mmHg, ET agent concentration < (Des 1%, Iso <=0.2%, Sevo <0.3%, oxygen saturation (SpO2) > 94%,Qualitative or quantitative Tetralogy of Fallot (TOF), Purposeful Movement, 5 second head lift, Spontaneous Respiratory Rate >=8 bpm at extubation, eye opening | Day 1 |
| Measure | Description | Time Frame |
|---|---|---|
| Number of Participants with Preoperative Exposures (ASA) American Society of Anesthesiologists Emergency Status | The classification system alone does not predict the perioperative risks, but used with other factors (eg, type of surgery, frailty, level of deconditioning), it can be helpful in predicting perioperative risks | Preoperative |
| Measure | Description | Time Frame |
|---|---|---|
| Hospital stay | length of stay | day 60 |
| 30 day Mortality Rate | 30 Day mortality obtained from the chart in order to determine association with intervention required at extubation |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients 60 years of age and older undergoing general anesthesia and non-cardiac surgery will be observed by a member of the research team independent from the team caring for the patient at the time of emergence and extubation
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Thomas W Templeton, MD | Wake Forest Health Sciences | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Wake Forest Health Sciences | Winston-Salem | North Carolina | 27157 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 11035684 | Background | Behrendt CE. Acute respiratory failure in the United States: incidence and 31-day survival. Chest. 2000 Oct;118(4):1100-5. doi: 10.1378/chest.118.4.1100. | |
| 26215247 | Background | Alvarez MP, Samayoa-Mendez AX, Naglak MC, Yuschak JV, Murayama KM. Risk Factors for Postoperative Unplanned Intubation: Analysis of a National Database. Am Surg. 2015 Aug;81(8):820-5. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Date | Date Unknown |
|---|---|---|
| Release | May 20, 2026 | |
| Reset | Jun 16, 2026 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| May 20, 2026 | Jun 16, 2026 | |||
| Jul 7, 2026 |
Not provided
Not provided
Not provided
| Number of Participants with Preoperative Exposures (COPD) Chronic obstructive pulmonary disease |
presence of COPD |
| Preoperative |
| Number of Participants with Preoperative Exposures (Dementia) | presence of dementia | Preoperative |
| Number of Participants with Preoperative Exposures (obstructive sleep apnea by history or STOP BANG) (snoring, tiredness, observed apnea, blood pressure, body mass index, age, neck circumference and gender) | obstructive sleep apnea SCORE >3 | Preoperative |
| Number of Participants with Preoperative Exposures (Sleep Disordered breathing by history or STOP BANG) (snoring, tiredness, observed apnea, blood pressure, body mass index, age, neck circumference and gender) | STOP BANG SCORE >3 | Preoperative |
| Number of Participants with Preoperative Exposures (Neuro-degenerative disorders) | Neuro-degenerative disorders such as: amyotrophic lateral sclerosis, Parkinson's, multiple sclerosis, Alzheimer's, Huntington's | Preoperative |
| Number of Participants with Preoperative Exposures (Heart failure) | by history or documented echo | Preoperative |
| Number of Participants with Preoperative Exposures (Opioid naïve) | by history or from electronic health record | Preoperative |
| Number of Participants with Preoperative Exposures (Diabetes) | presence of diabetes mellitus | Preoperative |
| Number of Participants with Preoperative Exposures (ESRD) End-Stage Renal Disease | presence of end-stage renal disease | Preoperative |
| Number of Participants with Preoperative Exposures (CVA) cerebrovascular accident - medical term for a stroke | Preoperative |
| Number of Participants with Preoperative Exposures (Chronic Restrictive Lung disease) | Preoperative |
| Number of Participants with Preoperative Exposures (Current Smoker) | current smoker or >=20 year pack history | Preoperative |
| Number of Participants with Preoperative Exposures (Inhalational agent used for maintenance) | Anesthetic maintenance agent used at time of extubation | Preoperative |
| Number of Participants with Preoperative Exposures (Use of (NMB) Neuromuscular Blocker | during procedure |
| Number of Participants with Preoperative Exposures (Use of Midazolam) | during procedure |
| Number of Participants with Preoperative Exposures (Use of opioid agonist during preoperative or intraoperative phase) | during procedure |
| Number of Participants with Preoperative Exposures (Use of blood or other blood products such as platelets, FFP(Fresh frozen plasma), or Cryo) | during procedure |
| Number of Participants with Preoperative Exposures (Regional Anesthesia other than local infiltration) | during procedure |
| Number of Participants with Preoperative Exposures (Type of inhalational agent used for maintenance) | Qualitative measures will be used to analyze this Outcome Measure | during procedure |
| Number of Participants with Preoperative Exposures (Use of train of 4 monitoring) | A peripheral nerve stimulator, also known as a train-of-four monitor, is used to assess neuromuscular transmission when neuromuscular blocking agents (NMBAs) are given to block musculoskeletal activity | during procedure |
| Number of Participants with Preoperative Exposures (Use of Sugammadex for reversal) | during procedure |
| Number of Participants with Preoperative Exposures (Use of Neostigmine for reversal) | during procedure |
| Anesthesia Time during procedure | during procedure |
| Number of Participants with Preoperative Exposures (Difficult Airway) | Difficult Airway or use of alternative airway technique other than DL because of suspected difficulty with the airway | during procedure |
| Number of Participants with Preoperative Exposures (Intracranial Procedure) | during procedure |
| Number of Participants with Preoperative Exposures (positive end-expiratory pressure (PEEP) | (PEEP) positive end-expiratory pressure >7 cmH2O for >10 minutes | during procedure |
| Number of Participants with Preoperative Exposures (Surgical Procedure) | during procedure |
| Number of Participants with Preoperative Exposures (Open Abdominal) | during procedure |
| Number of Participants with Preoperative Exposures (Laparoscopic or Robotic Procedure) | during procedure |
| IV fluid volume | during procedure |
| volume of blood products | during procedure |
| types of blood products | during procedure |
| Number of Participants with Preoperative Exposures (use of colloid) | during procedure |
| volume of colloid | during procedure |
| day 30 |
| 27185683 | Background | Tillquist MN, Gabriel RA, Dutton RP, Urman RD. Incidence and risk factors for early postoperative reintubations. J Clin Anesth. 2016 Jun;31:80-9. doi: 10.1016/j.jclinane.2015.12.038. Epub 2016 Apr 12. |